Anika Therapeutics Inc. (ANIK)
NASDAQ: ANIK
· Real-Time Price · USD
8.80
0.16 (1.85%)
At close: Aug 15, 2025, 3:08 PM
Anika Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -56.74M | -56.38M | -97.52M | -74.18M | -76.83M | -82.67M | -24.57M | -22.17M | -22.28M | -14.86M | -15.74M | -11.01M | -1.64M | 4.13M | -5.73M | -12.7M | -26.94M |
Depreciation & Amortization | 7.11M | 8.12M | 9.9M | 11.79M | 13.28M | 14.23M | 14.31M | 14.26M | 14.42M | 14.49M | 14.55M | 14.63M | 14.43M | 14.32M | 14.09M | 14.02M | 14.21M |
Stock-Based Compensation | 12.4M | 13.13M | 14.69M | 14.86M | 15.12M | 15.24M | 15.24M | 15.56M | 15.49M | 14.31M | 13.67M | 12.65M | 11.37M | 11.09M | 9.35M | 8.41M | 7.85M |
Other Working Capital | 6.44M | 6.2M | 7.89M | -1.57M | -3.89M | 589K | -46K | -2.71M | 4.21M | -1.28M | -2.27M | -4.59M | -3.12M | -783K | -1.05M | 2.19M | -4.93M |
Other Non-Cash Items | 55.34M | 65.84M | 108.02M | 93.89M | 79.69M | 69.85M | 8.32M | 8.35M | 7.76M | 7.56M | 10.65M | 6.55M | -2.91M | -4.66M | 9.78M | 18.46M | 37.27M |
Deferred Income Tax | 85K | 260K | -1.82M | -2.84M | -3.76M | -6.33M | -6.26M | -6.53M | -7.37M | -5.27M | -6.28M | -4.98M | -877K | -1.77M | 777K | -1.44M | -5.25M |
Change in Working Capital | 1.55M | -2.36M | -2.61M | -11.39M | -16.94M | -12.12M | -11.98M | -18.19M | -5.36M | -11.82M | -8.45M | -10.1M | -11.41M | -14.72M | -21.75M | -16.43M | -17.55M |
Operating Cash Flow | 5.4M | 5.4M | 7.46M | 8.93M | 1.7M | -1.79M | -4.95M | -8.72M | 2.66M | 4.41M | 8.4M | 7.75M | 8.96M | 8.4M | 6.51M | 10.31M | 9.59M |
Capital Expenditures | -8.75M | -7.73M | -8.27M | -7.79M | -5.85M | -5.43M | -6.12M | -7.07M | -7.55M | -7.49M | -6.08M | -5.68M | -6.05M | -5.14M | -4.46M | -3.45M | -1.32M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113K | -124K | -126K | -476K | -1.1M | -1.09M | -1.97M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.25M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M | 20.5M | 27.5M | 32.51M |
Other Investing Acitivies | 3.9M | -600K | -600K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M | 20.5M | 27.5M | 26.26M |
Investing Cash Flow | -4.85M | -8.33M | -8.87M | -7.79M | -5.85M | -5.43M | -6.12M | -7.07M | -7.55M | -7.49M | -6.2M | -5.8M | -6.18M | -3.12M | 14.93M | 22.95M | 22.97M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -231K | -253K | -284K | -275K | -107K | -113K | -201K | -25.26M | -50.35M | -677K |
Common Stock Repurchased | -14.88M | -13.21M | -7.63M | -3.77M | -7.4M | -5.1M | -5.11M | -5.06M | -88K | -934K | -998K | -1M | -1M | -486K | -461K | -415K | -453K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.69M | -2.5M | -2.16M | -2.25M | -2.47M | -1.81M | -1.49M | -5.75M | -5.35M | -4.57M | -5.18M | -7.72M | -7.08M | -6.58M | -9.69M | -2.79M | -3.41M |
Financial Cash Flow | -15.89M | -12.73M | -7.03M | -3.15M | -6.98M | -6.32M | -6M | -10.5M | -5.6M | -4.85M | -5.46M | -7.83M | -7.19M | -6.78M | -34.95M | -53.15M | -4.08M |
Net Cash Flow | -15.26M | -15.71M | -8.28M | -2.25M | -11.11M | -13.46M | -17.13M | -26.32M | -10.59M | -8.06M | -3.2M | -5.79M | -4.27M | -1.43M | -13.24M | -19.57M | 28.77M |
Free Cash Flow | -3.35M | -2.33M | -808K | 1.14M | -4.14M | -7.21M | -11.06M | -15.79M | -4.89M | -3.08M | 2.32M | 2.08M | 2.91M | 3.25M | 2.05M | 6.86M | 8.27M |